ES433135A1 - Procedimiento para preparar arildihidropiridazinonas susti-tuidas. - Google Patents

Procedimiento para preparar arildihidropiridazinonas susti-tuidas.

Info

Publication number
ES433135A1
ES433135A1 ES433135A ES433135A ES433135A1 ES 433135 A1 ES433135 A1 ES 433135A1 ES 433135 A ES433135 A ES 433135A ES 433135 A ES433135 A ES 433135A ES 433135 A1 ES433135 A1 ES 433135A1
Authority
ES
Spain
Prior art keywords
hydroxypropoxyaryl
pyridazinones
dihydro
substituted amino
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES433135A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES433135A1 publication Critical patent/ES433135A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES433135A 1973-12-19 1974-12-19 Procedimiento para preparar arildihidropiridazinonas susti-tuidas. Expired ES433135A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58726/73A GB1488330A (en) 1973-12-19 1973-12-19 Dihydropyridazinones

Publications (1)

Publication Number Publication Date
ES433135A1 true ES433135A1 (es) 1976-11-16

Family

ID=10482281

Family Applications (1)

Application Number Title Priority Date Filing Date
ES433135A Expired ES433135A1 (es) 1973-12-19 1974-12-19 Procedimiento para preparar arildihidropiridazinonas susti-tuidas.

Country Status (18)

Country Link
US (1) US3931177A (es)
JP (1) JPS5093984A (es)
BE (1) BE823103A (es)
CA (1) CA1033733A (es)
CH (1) CH608794A5 (es)
DE (1) DE2459468A1 (es)
DK (1) DK142870B (es)
ES (1) ES433135A1 (es)
FI (1) FI356974A (es)
FR (1) FR2255070B1 (es)
GB (1) GB1488330A (es)
HU (1) HU170633B (es)
IE (1) IE40428B1 (es)
IL (1) IL46158A (es)
NL (1) NL7416578A (es)
SE (1) SE413405B (es)
SU (1) SU578872A3 (es)
ZA (1) ZA747462B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111936A (en) * 1974-06-18 1978-09-05 Smith Kline & French Laboratories Limited Pyridazinethiones
US4082843A (en) * 1975-11-26 1978-04-04 Smith Kline & French Laboratories Limited 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
US4281125A (en) * 1980-05-15 1981-07-28 Diamond Shamrock Corporation Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ATE13294T1 (de) * 1981-03-04 1985-06-15 Ciba Geigy Ag Pyridazinone, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen und deren verwendung.
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
GB8426804D0 (en) * 1984-10-23 1984-11-28 Ciba Geigy Ag Pyridazinones preparations
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3934436A1 (de) * 1989-06-01 1991-04-18 Thomae Gmbh Dr K 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
NZ530051A (en) 2001-06-12 2006-12-22 Wellstat Therapeutics Corp Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders
JP2006509790A (ja) * 2002-11-27 2006-03-23 アルテシアン セラピューティック,インコーポレイティド 心不全の治療のための混合されたPDE阻害およびβアドレナリン拮抗薬活性または部分的作用薬活性を有する化合物
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
CA2588949A1 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
ATE540675T1 (de) 2005-04-01 2012-01-15 Wellstat Therapeutics Corp Verbindungen zur behandlung von stoffwechselstörungen
SI2069312T1 (sl) 2006-07-25 2013-03-29 Cephalon, Inc. Derivati piridizinona
JP2010523579A (ja) * 2007-04-02 2010-07-15 インスティテュート フォア ワンワールド ヘルス Cftr阻害剤化合物およびそれらの使用
US8354557B2 (en) * 2008-06-17 2013-01-15 Concert Pharmaceuticals, Inc. Synthesis of deuterated morpholine derivatives
KR20160003647A (ko) 2013-03-15 2016-01-11 에피자임, 인코포레이티드 Carm1 억제제 및 이의 용도
US9718816B2 (en) 2013-03-15 2017-08-01 Epizyme, Inc. 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof
US9346802B2 (en) 2013-03-15 2016-05-24 Epizyme, Inc. CARM1 inhibitors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689652A (en) * 1970-10-09 1972-09-05 William Vincent Curran Method of lowering blood pressure in mammals
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones

Also Published As

Publication number Publication date
IE40428L (en) 1975-06-19
DK142870B (da) 1981-02-16
JPS5093984A (es) 1975-07-26
HU170633B (es) 1977-07-28
AU7572474A (en) 1976-05-27
SE7415691L (es) 1975-06-23
DK142870C (es) 1981-09-21
US3931177A (en) 1976-01-06
ZA747462B (en) 1975-12-31
CA1033733A (en) 1978-06-27
IL46158A (en) 1978-08-31
SU578872A3 (ru) 1977-10-30
FR2255070B1 (es) 1979-09-21
FR2255070A1 (es) 1975-07-18
SE413405B (sv) 1980-05-27
NL7416578A (nl) 1975-06-23
IE40428B1 (en) 1979-05-23
CH608794A5 (es) 1979-01-31
GB1488330A (en) 1977-10-12
BE823103A (fr) 1975-06-09
FI356974A (es) 1975-06-20
IL46158A0 (en) 1975-02-10
DK634074A (es) 1975-08-25
DE2459468A1 (de) 1975-07-03

Similar Documents

Publication Publication Date Title
ES433135A1 (es) Procedimiento para preparar arildihidropiridazinonas susti-tuidas.
GB1034160A (en) Angle adjusting mechanism for optical elements
DK423783D0 (da) Stel, navnlig til opstillelige moebler, f. eks. med hylder
DK131904B (da) Analogifremgangsmåde til fremstilling af 1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepinderivater.
DK140638B (da) Analogifremgangsmåde til fremstilling af s-triazolo(1,5-a)(1,4)benzodiazepinderivater.
IT8222829A0 (it) Apparecchio riproduttore, particolarmente del tipo per ufficio.
PH19512A (en) Benzotriazolyl-4,5-dihydro-3(2h)-pyridazinones
DK114767B (da) Analogifremgangsmåde til fremstilling af 1,1-diphenyl-2-methyl-3-(benzylidenamino)propanoler.
ES431574A1 (es) Un metodo para preparar un compuesto de la serie 2-furoatos de 3-dietilamino-2, 2-dimetilpropilo-5-(fenilsustituido).
CA925509A (en) 5-methyldipyrazolo (3,4-b:3',4'-d) pyridin-3-(2h) -ones
DK105531C (da) Fremgangsmåde til fremstilling af 6-(5-nitro-2-furyl)-3-(2H)-pyridazinonforbindelser.
ES445073A1 (es) Procedimiento para preparar derivados de 5-nitrotiazolilimi-dazolidina.
AU479912B2 (en) Substituted 4,5-dihydro-3(2h)-pyridazinones
GB1290335A (es)
GB1267071A (es)
DK127784B (da) Fremgangsmåde til fremstilling af 1-aryl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-oner.
CA731648A (en) 4,5-dihydro-6-(5-nitro-2-furyl)-as-triazin-or pyridazin-3(2h)-one
ES285714U (es) Mecanismo de corredera para asientos
Mohandas The Madras Police Journal Vol. 15, No. 4 (Oct-Dec)
CA956313A (en) 1,4-dihydro-1,4-etheno-isoquinolin-3(2h)-ones
DK148536C (da) Analogifremgangsmaade til fremstilling af 6-phenyl-4,5-dihydro-3(2h)-pyridazinoner
GB1099037A (en) Improvements in or relating to gramophones
DK104983C (da) Fremgangsmåde til fremstilling af 1,3-substituerede 2-azetidinoner.
CA683192A (en) 4,17.alpha.-DIMETHYL-9.alpha.-FLUOROTESTOSTERONES
GB1304663A (es)